Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) for intermediate-risk PCa, aiming to
selectively target localized cancerous lesions while preserving healthy tissue
on field-like signs. In the second stage, one of the variants is
selected and realized through point
Blinov, Andrey,
Nagdalian, Andrey,
Rzhepakovsky, Igor,
Rekhman, Zafar,
Askerova, Alina,
Agzamov, Vadim,
Kayumov, Umedzhon,
Tairov, Dilshod,
Ibrahimov, Sobirzhon,
Sayahov, Ilgiz (2025) was
selected as the optimal stabilizing agent. Interestingly, 10 mg of CC-NPs+HA powder caused 100% mortality
Erdman, V.V.,
Karimov, D.D.,
Tuktarova, I.A.,
Petintseva, A.A.,
Timasheva, Y.R.,
Nasibullin, T.R. (2025) selected from the sample of Tatars residing in the Republic of Bashkortostan (total 1790 people from 18